Bevacizumab, Irinotecan, or Topotecan Added to Temozolomide for Children With Relapsed and Refractory Neuroblastoma: Results of the ITCC-SIOPEN BEACON-Neuroblastoma Trial.

Overview of attention for article published in Journal of Clinical Oncology, January 2024

Altmetric Badge

About this Attention Score

In the top 5% of all research outputs scored by Altmetric
One of the highest-scoring outputs from this source (#5 of 22,282)
High Attention Score compared to outputs of the same age (99th percentile)
High Attention Score compared to outputs of the same age and source (99th percentile)

Mentioned by

news: 171 news outlets
blogs: 1 blog

twitter: 14 X users

Citations

dimensions_citation: 1 Dimensions

Readers on

mendeley: 10 Mendeley

Summary News Blogs X Dimensions citations

So far, Altmetric has seen 1 blog post.

Children with neuroblastomas may benefit from new drug cocktail

news-medical.net, 09 Jan 2024

Children who develop neuroblastomas, a rare form of cancer which develops in nerve cells, may benefit from receiving certain…

This page shows the most recent blog posts that mention this research output.

Click here to find out how to access more activity.